Company intelligence / Profile preview

Dollvet

Şanlıurfa, Şanlıurfa, Turkeydollvet.com.tr ↗

Ownership: Private
Employees: ~117
Development stage: Other

Overview

Dollvet operates one of Turkey’s leading GMP-certified biotechnology centers with a strong focus on the development and commercial production of high-quality veterinary vaccines against epidemic diseases. The company has significant R&D capabilities certified by the Ministry of Industry and Trade. While its main business today centers on animal health, it also claims technical capacity for human vaccine/medicine manufacturing. As of recent data, Dollvet holds at least 26 veterinary vaccine licenses and three test kit licenses.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologicSmall moleculeProtein
Industry: Veterinary

Beyond the preview

Go deeper on Dollvet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dollvet.

Explore the full profile